rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Edward Stelmakh

Chief Finance & Strat Officer

Company insider

Files Form 4 as: Chief Finance & Strat Officer, OptimizeRx.

In numbers

Trades disclosed
48
Buys
1
Sells
1
Bought
$46K
Sold
$19K
Companies
1
Companies where not an officer
0
First trade
11 Oct 2021
Last trade
21 Aug 2026
Last filed
24 Aug 2026

Companies traded

Where they are an officer
OPRX OptimizeRxOfficer · Business Services · last 21 Aug 20261 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month. 2 lines have no legible date and are left out.

Every trade

TradedCompanyWhatAmount
21 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$11K1,381 at $7.71filing
21 Aug 2026filed 24 Aug 2026OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$11K1,381 at $7.71filing
23 Dec 2025filed 23 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$47K3,658 at $12.74filing
19 Dec 2025filed 23 Dec 2025OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2025filed 23 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2025filed 23 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$19K1,388 at $13.51filing
19 Dec 2025filed 22 Dec 2025OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2025filed 22 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2025filed 22 Dec 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Sold$19K1,388 at $13.51filing
3 Oct 2025filed 7 Oct 2025OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—16,623 at $0.00filing
3 Oct 2025filed 7 Oct 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—16,623 at $0.00filing
3 Oct 2025filed 7 Oct 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$83K4,406 at $18.75filing
21 Aug 2025filed 25 Aug 2025OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—35,156 at $0.00filing
21 Aug 2025filed 25 Aug 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—15,625 at $0.00filing
15 Feb 2025filed 20 Feb 2025OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$14K2,156 at $6.64filing
23 Dec 2024filed 27 Dec 2024OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code A—77,742 at $0.00filing
23 Dec 2024filed 27 Dec 2024OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code A—41,408 at $0.00filing
19 Dec 2024filed 20 Dec 2024OPRX OptimizeRxoption or derivative · Business ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2024filed 20 Dec 2024OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code M—5,237 at $0.00filing
19 Dec 2024filed 20 Dec 2024OPRX OptimizeRxBusiness ServicesSEC FORM 4 Code F$6,2511,316 at $4.75filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Industrials2

Buys in green, sells in red, by the company’s sector.

Related people

Andrew J. D'SilvaChief Business Officer · Chief Business Officer at OptimizeRx, filing Form 4 there in the last year
Stephen L. SilvestroChief Executive Officer · Chief Executive Officer at OptimizeRx, filing Form 4 there in the last year
Marion Odence-FordChief Legal & Admin Officer · Chief Legal & Admin Officer at OptimizeRx, filing Form 4 there in the last year
Brendan W. MerrellChief Operating Officer · Chief Operating Officer at OptimizeRx, filing Form 4 there in the last year
James Paul LangDirector · Director at OptimizeRx, filing Form 4 there in the last year